NL9001998A - Extracellulair exopolymeer, werkwijze voor de bereiding ervan en farmaceutische samenstellingen die het exopolymeer bevatten. - Google Patents

Extracellulair exopolymeer, werkwijze voor de bereiding ervan en farmaceutische samenstellingen die het exopolymeer bevatten. Download PDF

Info

Publication number
NL9001998A
NL9001998A NL9001998A NL9001998A NL9001998A NL 9001998 A NL9001998 A NL 9001998A NL 9001998 A NL9001998 A NL 9001998A NL 9001998 A NL9001998 A NL 9001998A NL 9001998 A NL9001998 A NL 9001998A
Authority
NL
Netherlands
Prior art keywords
exopolymer
daltons
extracellular
culture medium
molecular weight
Prior art date
Application number
NL9001998A
Other languages
English (en)
Dutch (nl)
Original Assignee
Om Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Om Lab Sa filed Critical Om Lab Sa
Publication of NL9001998A publication Critical patent/NL9001998A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL9001998A 1989-09-29 1990-09-11 Extracellulair exopolymeer, werkwijze voor de bereiding ervan en farmaceutische samenstellingen die het exopolymeer bevatten. NL9001998A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3536/89A CH679677A5 (ru) 1989-09-29 1989-09-29
CH353689 1989-09-29

Publications (1)

Publication Number Publication Date
NL9001998A true NL9001998A (nl) 1991-04-16

Family

ID=4258109

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9001998A NL9001998A (nl) 1989-09-29 1990-09-11 Extracellulair exopolymeer, werkwijze voor de bereiding ervan en farmaceutische samenstellingen die het exopolymeer bevatten.

Country Status (37)

Country Link
US (1) US5114848A (ru)
JP (1) JPH03170503A (ru)
KR (1) KR910006489A (ru)
AR (1) AR242263A1 (ru)
AT (1) ATA188490A (ru)
AU (1) AU644604B2 (ru)
BE (1) BE1004569A3 (ru)
BG (1) BG60275B2 (ru)
BR (1) BR9004147A (ru)
CA (1) CA2025155A1 (ru)
CH (1) CH679677A5 (ru)
CZ (1) CZ466590A3 (ru)
DD (1) DD295764A5 (ru)
DE (1) DE4028018A1 (ru)
DK (1) DK191290A (ru)
EG (1) EG19285A (ru)
ES (1) ES2025972A6 (ru)
FI (1) FI95483C (ru)
FR (1) FR2652590B1 (ru)
GB (1) GB2244998B (ru)
GR (1) GR900100706A (ru)
HU (1) HU210826B (ru)
IT (1) IT1243709B (ru)
LU (1) LU87809A1 (ru)
MA (1) MA21945A1 (ru)
NL (1) NL9001998A (ru)
NO (1) NO178345C (ru)
NZ (1) NZ235338A (ru)
PE (1) PE15391A1 (ru)
PL (1) PL165512B1 (ru)
PT (1) PT95346A (ru)
RU (2) RU2023445C1 (ru)
SE (1) SE9002557L (ru)
TN (1) TNSN90122A1 (ru)
TR (1) TR25353A (ru)
YU (1) YU47646B (ru)
ZA (1) ZA906492B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2276728T3 (es) 2001-02-23 2007-07-01 Chemisches Laboratorium Dr. Kurt Richter Gmbh Composicion de uso topico.
WO2005034971A2 (en) * 2003-10-08 2005-04-21 Masami Moriyama Antiviral agent
RU2373957C2 (ru) 2006-10-13 2009-11-27 Александр Метталинович Тишин Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его
KR20100020938A (ko) * 2007-05-04 2010-02-23 앨러멘터리 헬스 리미티드 엑소폴리사카라이드

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103194A (en) * 1980-01-23 1981-08-18 Meiji Seika Kaisha Ltd Antitumor substance and its preparation
US4435389A (en) * 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
JPS58203913A (ja) * 1982-05-25 1983-11-28 Meiji Milk Prod Co Ltd 高分子多糖類物質mps−82及びその利用
JPS59118712A (ja) * 1982-12-27 1984-07-09 Morinaga Milk Ind Co Ltd 抗腫瘍剤及びその製造法
JPS61257930A (ja) * 1985-05-09 1986-11-15 Morinaga Milk Ind Co Ltd 感染防御剤
US4701907C1 (en) * 1986-02-03 2002-08-27 Collins Mary Dynamically reconfigurable time-space-time digital switch and network
EP0295961A3 (en) * 1987-06-18 1989-07-12 Kureha Kagaku Kogyo Kabushiki Kaisha Polysaccharides and antiviral drug containing polysaccharides as active ingredient

Also Published As

Publication number Publication date
DD295764A5 (de) 1991-11-14
NO904041D0 (no) 1990-09-17
GB9020112D0 (en) 1990-10-24
MA21945A1 (fr) 1991-04-01
FR2652590A1 (fr) 1991-04-05
HU905988D0 (en) 1991-03-28
US5114848A (en) 1992-05-19
HUT61333A (en) 1992-12-28
JPH03170503A (ja) 1991-07-24
BE1004569A3 (fr) 1992-12-15
IT1243709B (it) 1994-06-21
CZ466590A3 (en) 1997-03-12
HU210826B (en) 1995-08-28
PE15391A1 (es) 1991-05-04
EG19285A (en) 1994-10-30
TR25353A (tr) 1993-03-01
LU87809A1 (fr) 1991-02-18
DK191290D0 (da) 1990-08-10
RU2023445C1 (ru) 1994-11-30
RU2025127C1 (ru) 1994-12-30
BG60275B1 (bg) 1994-03-31
NO178345C (no) 1996-03-06
PT95346A (pt) 1991-05-22
ATA188490A (de) 1997-05-15
YU156990A (sh) 1992-12-21
ZA906492B (en) 1991-05-29
FR2652590B1 (fr) 1993-06-25
AU6263190A (en) 1991-04-11
GR900100706A (el) 1992-01-20
KR910006489A (ko) 1991-04-29
IT9021332A0 (it) 1990-08-29
PL286821A1 (en) 1991-11-04
FI95483B (fi) 1995-10-31
FI903777A0 (fi) 1990-07-27
GB2244998B (en) 1993-10-06
DE4028018A1 (de) 1991-04-11
SE9002557D0 (sv) 1990-08-02
SE9002557L (sv) 1991-03-01
ES2025972A6 (es) 1992-04-01
NZ235338A (en) 1991-09-25
NO178345B (no) 1995-11-27
CH679677A5 (ru) 1992-03-31
BR9004147A (pt) 1991-09-03
GB2244998A (en) 1991-12-18
BG60275B2 (en) 1994-03-31
YU47646B (sh) 1995-12-04
CA2025155A1 (en) 1991-03-30
IT9021332A1 (it) 1992-02-29
PL165512B1 (pl) 1994-12-30
NO904041L (no) 1991-04-02
AR242263A1 (es) 1993-03-31
FI95483C (fi) 1996-02-12
TNSN90122A1 (fr) 1991-03-05
AU644604B2 (en) 1993-12-16
DK191290A (da) 1991-03-30

Similar Documents

Publication Publication Date Title
US7157443B2 (en) Staphylococcus aureus exopolysaccharide and process
JPH09512708A (ja) グルカンの酵素処理
EP0037522B1 (fr) Dérivés de l'entérotoxine thermostable de Escherichia Coli et leur préparation
US20070031447A1 (en) Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides
EP0089266B2 (fr) Procédé de préparation de protéoglycanes immunostimulants inducteurs d'interféron, protéoglycanes obtenus et médicament les contenant
NL9001998A (nl) Extracellulair exopolymeer, werkwijze voor de bereiding ervan en farmaceutische samenstellingen die het exopolymeer bevatten.
CA2063721C (fr) Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae
CA1339308C (en) Polysaccharides and antiviral drug containing polysaccharides as active ingredient
US4233291A (en) Novel biological substance from a fungus and the process for producing the same
JPS58318B2 (ja) 制癌性物質の製造方法
KR860001213B1 (ko) 제암 및 면역자극 작용을 갖는 물질의 제조방법
JPH08208704A (ja) 新規な糖タンパク質複合体、その製造方法、並びに抗腫瘍剤、免疫調節剤及び増殖因子阻害剤
JPH0645547B2 (ja) 免疫増強剤
JPH0816119B2 (ja) 蛋白多糖体kv−071及びそれを有効成分とするヒトロタウイルス感染症予防剤
JP2000143522A (ja) 免疫寛容誘導剤
EP0230556A1 (en) Fraction obtained from Listeria monocytogenes having therapeutical activity, process for its preparation and pharmaceutical compositions containing it

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed